
Vin Arx Pharmaceuticals Private Limited
About Vin Arx Pharmaceuticals Private Limited
Data last updated:
Vin Arx Pharmaceuticals Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 February 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909HR2022PTC101549. Its GSTIN is 06AAICV5736F1Z6 (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.6 Lakh. It is led by directors Gaurav Gupta and Sorabh Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 274 Industrial Area Phase – 1, Panchkula, Haryana, India – 134113.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.75 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.39 Lakh (net margin 0.8%) and EBITDA of ₹3.69 Lakh (EBITDA margin 2.1%).
As per MCA filings, the company has open charges of ₹50 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Vin Arx Pharmaceuticals Private Limited's registered office is in Panchkula, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 274 Industrial Area Phase – 1, Panchkula, Haryana, India – 134113
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vin Arx Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vin Arx Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Vin Arx Pharmaceuticals Private Limited, buy the company report.
Financials of Vin Arx Pharmaceuticals Private Limited
FY 2025 filings availableVin Arx Pharmaceuticals Private Limited reported revenue of ₹1.75 Cr (up 197% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 197% in the latest year. EBITDA rose 76% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.69 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.39 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.1% | |||
| Net Profit Margin | 0.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Vin Arx Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vin Arx Pharmaceuticals Private Limited
Vin Arx Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Gupta | Director | 22 Feb 2022 | 4 Years 8 Months | Current |
| Sorabh Gupta | Director | 22 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Vin Arx Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stoicure Pharmaceuticals Private Limited | ₹1.76 Cr (FY 2024) | 432.0% | Ahmedabad, Gujarat, India | |||
| Vin Arx Pharmaceuticals Private Limitedthis company | ₹1.75 Cr (FY 2025) | ₹1.39 Lakh | 0.8% | 197.0% | Panchkula, Haryana, India | |
| Shrijan Pharmaceuticals Private Limited | ₹1.74 Cr (FY 2024) | 11.0% | Uttar Pradesh, India | |||
| Sandmartin Pharmaceuticals Private Limited | ₹1.74 Cr (FY 2025) | 16.0% | New Delhi, Delhi, India | |||
| Aanyas Pharmaceuticals India Private Limited | ₹1.73 Cr (FY 2024) | 4.0% | Raipur, Chhattisgarh, India |
To see the full peer comparison of Vin Arx Pharmaceuticals Private Limited, buy the company report.
Auditor
Vin Arx Pharmaceuticals Private Limited is audited by KBB & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KBB & CO. | FY 2023 | 023819N |
Shareholding
The shareholding of Vin Arx Pharmaceuticals Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Vin Arx Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Mar 2023 | 100720983 | Others | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Vin Arx Pharmaceuticals Private Limited has 2 court cases on record: 2 filed by Vin Arx Pharmaceuticals. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panchkula, Haryana | Civil suit | Filed by the company against M/S QNQ Healthcare Pvt Ltd and 1 other | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S New Mukut Medical Agency and 1 other | Disposed |
To see the full case history of Vin Arx Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vin Arx Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vin Arx Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAICV5736F1Z6 | Haryana | Active | 15 Jan 2023 |
To see the full GST registrations and return filing status of Vin Arx Pharmaceuticals Private Limited, buy the company report.
Recent activity
Vin Arx Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Gaurav Gupta was appointed as Director on 22 Feb 2022.
Frequently asked questions
Vin Arx Pharmaceuticals is an active private limited company based in Panchkula, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 February 2022 (4+ years old) and is registered under CIN U51909HR2022PTC101549.
Vin Arx Pharmaceuticals has 2 current directors:
- Gaurav Gupta - Director
- Sorabh Gupta - Director
The latest financial statements of Vin Arx Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Vin Arx Pharmaceuticals is 06AAICV5736F1Z6, registered in Haryana.
The CIN (Corporate Identification Number) of Vin Arx Pharmaceuticals is U51909HR2022PTC101549. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vin Arx Pharmaceuticals has 2 court cases on record: 2 filed by the company. 1 is pending.
Vin Arx Pharmaceuticals was incorporated on 22 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Vin Arx Pharmaceuticals by revenue are Stoicure Pharmaceuticals Private Limited, Shrijan Pharmaceuticals Private Limited, Sandmartin Pharmaceuticals Private Limited, Aanyas Pharmaceuticals India Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Gaurav Gupta was appointed as Director on 22 Feb 2022. Sorabh Gupta was appointed as Director on 22 Feb 2022.
The registered office of Vin Arx Pharmaceuticals is at Plot No. 274 Industrial Area Phase – 1, Panchkula, Haryana, India – 134113.
Vin Arx Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

